Skin Vaccination Summit 2017

22-24 May 2017, Leiden University Medical Centre, Leiden, The Netherlands

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Provisional Conference Programme | Monday 22nd May 2017

08.00
Arrival & Registration & Poster-Set-Up

09.20-09.30
Welcome to Leiden
Joke Bouwstra (Leiden/Amsterdam Center for Drug Research, Amsterdam, The Netherlands)

SESSION 1:
OPENING PLENARY SESSION

Moderator: Joke Bouwstra (Leiden/Amsterdam Center for Drug Research, Amsterdam, The Netherlands)

09.30-10.00
‘How can skin be utilized for improved vaccines?’
Mark Kendall (University of Queensland, Brisbane, Queensland, Australia)

10.00-10.30
‘Immunotherapy of cancer’
Ferry Ossendorp (Leiden University Medical Centre, Leiden, The Netherlands)

10.30-11.00
‘Challenges and opportunities raised by dermal immunization’
Liane Smith (Sanofi Pasteur, Toronto, Ontario, Canada)

11.00-11.30
Coffee Break & Poster Set-Up

SESSION 2:
PLENARY

Moderator: Bruce Weniger (Chiang Mai University, Chiang Mai, Thailand)

11.30-12.00
‘Migration of cells using human skin models’
Esther de Jong (University of Amsterdam, Amsterdam, The Netherlands)

12.00-12.30
‘Role of tissue-resident memory T cells in protective immunity: Implications for vaccination’
Marcel B.M. Teunissen (University of Amsterdam, Amsterdam, The Netherlands)

12.30-13.00
‘Modelling of uptake and trafficking of DCs’
Cees W.J. Oomens (Eindhoven University, Eindhoven, The Netherlands)

13.00-14.30
Lunch Break & Posters

SESSION 3:
SKIN TOPICS

Moderator: Marcel B.M. Teunissen (University of Amsterdam, Amsterdam, The Netherlands)

14.30-15.00
‘Skin biomarkers in vaccination’
Behazine Combadiere (Centre d’Immunologie et des Maladies Infectieuses Cimi-Paris, Paris, France)

15.00-15.20
‘Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy’
Richard Weiss (University of Salzburg, Salzburg, Austria)

15.20-15.40
‘Sialic Acid receptors and Langerin on Langerhans cells in a human skin model for vaccination strategies against melanoma’
J. Lübbers, S. Duinkerken, R.J.E. Li, J.J. Garcia-Vallejo and Y. van Kooyk (VU University Medical Center, Amsterdam, the Netherlands)

15.40-16.00
‘Development of a vaccination strategy targeting human skin DC using tumor specific glyco-conjugates’
S. Duinkerken, C.M. Fehres, H. Kalay, M. Ambrosini, S.J. van Vliet, J.J. Garcia-Vallejo and Y. van Kooyk (VU University Medical Center, Amsterdam, The Netherlands)

16.00-16.30
Tea Break & Posters

SESSION 4:
MICRONEEDLES/MICROARRAYS I

Moderator: Mark Prausnitz (Georgia Institute of Technology, Atlanta, Georgia, USA)

16.30-17.00
‘Diphtheria toxoid coated microneedles for intradermal vaccination’
Joke Bouwstra (Leiden/Amsterdam Center for Drug Research, Amsterdam, The Netherlands)

17.00-17.20
‘Polymeric microneedle arrays as intradermal vaccination candidates: Making the right choices’
A.J. Courtenay, M.T.C. McCrudden and R.F. Donnelly (Queens University Belfast, Belfast, Co. Antrim, Northern Ireland, UK)

17.20-17.40
‘Technical approaches for microneedle-based dermal vaccine delivery’

K. van der Maaden, W. Jiskoot and J. Bouwstra (Leiden Academic Centre for Drug Research (LACDR), Leiden University, The Netherlands)

17.40-18.00
‘The MELISA® test in immune system disorders: Useful or useless?’
B. Palmieri1,2, C. Laurino1,2 and M. Vadalà1,2 (1 University of Modena and Reggio Emilia Medical School, Surgical Clinic, Modena, Italy; 2 Network of the Second Opinion, Modena (MO), Italy)

18.00-19.00
SVS 2017 Welcome Drinks Reception

 

SVS 2017 Delegates

Login details will be supplied after you have registered for the event.


SVS 2017 Sponsors

  • ONdrugDELIVERY
  • CIMI
  • DNAvaccine.com
  • 3M
  • Aldevron
  • Becton Dickinson
  • Debiotech
  • Nanopass
  • PATH
  • VisMederi
  • West
  • NatureGeneTherapy.com
  • Star Syringe
  • Univac
  • IDRI
  • Novartis Vaccines
  • Swiss Vaccine
  • Sanofi Pasteur
  • Corium

SVS 2017 Downloads

SVS 2017 Leaflet

SVS 2017 Mailing List

Name
E-mail Address
What is 3+2-1?